Literature DB >> 1642286

Uveitis associated with human T-cell lymphotropic virus type I.

M Mochizuki1, T Watanabe, K Yamaguchi, K Yoshimura, S Nakashima, M Shirao, S Araki, K Takatsuki, S Mori, N Miyata.   

Abstract

Seroepidemiologic, clinical, and virologic studies were performed to determine whether human T-cell lymphotropic virus type I was closely associated with uveitis in two hospitals. One hospital was in an endemic area of the virus (Miyakonojo, Miyazaki) and the other hospital was in a less endemic area (Kurume). In the endemic area, the seroprevalence of the virus in patients with uveitis without defined causes (35.4%, 62 of 175 patients) was significantly higher than that in patients with nonuveitic ocular diseases (16.1%, 42 of 261 patients), or in patients with uveitis with defined causes (10.3%, eight of 78 patients). The seroprevalence in younger patients (20 to 49 years of age) with uveitis without defined causes in the area was 44.8% (30 of 67 patients), whereas it was only 9.3% (ten of 107 patients) in the other two groups. A similar observation was recorded even in the less endemic area (Kurume). Because the seroprevalence of the virus in the general population is known to be low in younger patients and to increase with age, these findings were interpreted to indicate that the association of human T-cell lymphotropic virus type I with uveitis was significant. Most patients, particularly those aged 20 through 49 years, had an intermediate uveitis characterized by a moderate inflammation in the vitreous body accompanied by an iritis and retinal vasculitis. The ocular symptoms in the patients differed from those of other types of uveitis common in Japan (Behçet's disease, Vogt-Koyanagi-Harada's disease, and toxoplasmosis, for example).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1642286     DOI: 10.1016/s0002-9394(14)73974-1

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  42 in total

1.  Quantitative differences in HTLV-I antibody responses: classification and relative risk assessment for asymptomatic carriers and ATL and HAM/TSP patients from Jamaica.

Authors:  Yoshimi Enose-Akahata; Anna Abrams; Kory R Johnson; Elizabeth M Maloney; Steven Jacobson
Journal:  Blood       Date:  2012-02-07       Impact factor: 22.113

2.  Dermatological manifestations of individuals infected with human T cell lymphotropic virus type I (HTLV-I).

Authors:  Lorena Dantas; Eduardo Netto; Marshall J Glesby; Edgar M Carvalho; Paulo Machado
Journal:  Int J Dermatol       Date:  2013-09-30       Impact factor: 2.736

3.  High frequencies of human T-lymphotropic virus type I (HTLV-I) infection and presence of HTLV-II proviral DNA in blood donors with anti-thyroid antibodies.

Authors:  H Mine; H Kawai; K Yokoi; M Akaike; S Saito
Journal:  J Mol Med (Berl)       Date:  1996-08       Impact factor: 4.599

Review 4.  Analysis of ocular fluids for local antibody production in uveitis.

Authors:  J H de Boer; L Luyendijk; A Rothova; A Kijlstra
Journal:  Br J Ophthalmol       Date:  1995-06       Impact factor: 4.638

5.  Familial clustering of human T lymphotropic virus type 1 uveitis.

Authors:  S Araki; M Mochizuki; K Yamaguchi; T Watanabe; A Ono; K Yoshimura; M Shirao; N Miyata
Journal:  Br J Ophthalmol       Date:  1993-11       Impact factor: 4.638

6.  Prevalence of HTLV-I-associated uveitis in the Kanto Plain, Japan.

Authors:  M Ishioka; K Goto; S Nakamura; N Watanabe; E Uchio; K Saeki; S Ohno
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-08       Impact factor: 3.117

7.  New entities in uveitis.

Authors:  S Lightman
Journal:  Br J Ophthalmol       Date:  1993-05       Impact factor: 4.638

8.  Increased number of circulating HTLV-1 infected cells in peripheral blood mononuclear cells of HTLV-1 uveitis patients: a quantitative polymerase chain reaction study.

Authors:  A Ono; M Mochizuki; K Yamaguchi; N Miyata; T Watanabe
Journal:  Br J Ophthalmol       Date:  1995-03       Impact factor: 4.638

9.  Human T-cell lymphotropic virus type 1 tax among American blood donors.

Authors:  D Zucker-Franklin; B A Pancake
Journal:  Clin Diagn Lab Immunol       Date:  1998-11

10.  Human T lymphotropic virus type 1 uveitis after Graves' disease.

Authors:  K Yamaguchi; M Mochizuki; T Watanabe; K Yoshimura; M Shirao; S Araki; N Miyata; S Mori; T Kiyokawa; K Takatsuki
Journal:  Br J Ophthalmol       Date:  1994-03       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.